Anshuman Singh

Mr

ReTiSense Inc

Bengaluru, Karnataka India


IIT Kharagpur

About Me

Anshuman Singh is deeply passionate about two things - technology and education. Over the course of his career, he has tapped this passion to do impactful work in both areas. Anshuman has developed several creative technological solutions in career. His primary mission is to develop technical capability and build innovative solutions from India. With this goal, he founded ReTiSense in July 2014. ReTiSense is recognized worldwide as a high-potential startup that delivers deep biomechanics analysis for sports, healthcare and human motion research. The company won the Karnataka Govt's ELEVATE-100 Program in 2018, earning the recognition of Top 100 innovative startups in the region. The flagship product, Stridalyzer smart insoles range, made it to MSN's list of Best Inventions in 2015.

You have not backed any projects. Lets change that!
Discover Projects

No project created yet. Lets change that!
Discover Projects

No comments on any project yet. Lets change that!
Discover Projects

No likes on any project yet.. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No data found. Lets change that!
Discover Projects

No project reviewed yet. Lets change that!
Discover Projects

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.